Dr. Habib joined the center for brain sciences at the Hebrew University of Jerusalem, as an assistant professor (senior lecturer) in August 2018. Her lab is focused on studying aging-related pathologies such as Alzheimer’s disease. Combining computational biology, single-cell genomics, and genome-engineering technologies, to uncover how cross-talk between diverse cells in the brain and signaling between the brain and the aging body, are mediating neurodegenerative diseases and cognitive decline.
Dr. Habib obtained her Ph.D. in computational biology from the Hebrew University of Jerusalem, working with Prof. Nir Friedman and Prof. Hanah Margalit, studying gene expression regulation and trans-generational effects of diet. Naomi then undertook postdoctoral training, at the Broad Institute of MIT/Harvard working, with Dr. Feng Zhang and Dr. Aviv Regev, where she led the development of single nucleus RNA-sequencing technologies and applied it to define cellular diversity and molecular processes in the adult mammalian brain. She also took part in a team effort to develop the transformative CRISPR/Cas9 genome engineering technologies and its applications to functionally interrogate the brain.